Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Barton

Showing results (81-90 of 296) with videos related to

Pageof 30
Sort By:
Rheumatology Advances in Practice|February 28, 2024
Psoriatic arthritis: the role of self-reported non-adherence, non-trough drug levels, immunogenicity and conventional synthetic DMARD co-therapy in adalimumab and etanercept responsePhilippa D K Curry, Andrew P Morris, Meghna Jani, et al.
Arthritis and Rheumatism|December 16, 2003
Genetic variation in CCR5 does not predict clinical outcome in inflammatory arthritisSally John, Simon Smith, Jonathan F Morrison, et al.
Rheumatology Advances in Practice|February 26, 2025
Ultrasound-guided synovial tissue biopsy for people with rheumatoid arthritis: a micro-costing studySainan Chang, Felice Rivellese, Katherine Payne, et al.
RMD Open|February 6, 2016
Psychological factors predict adherence to methotrexate in rheumatoid arthritis; findings from a systematic review of rates, predictors and associations with patient-reported and clinical outcomesHolly F Hope, James Bluett, Anne Barton, et al.
Patient Preference and Adherence|March 5, 2026
Development of a Complex Biofeedback-Based Intervention to Improve Methotrexate Adherence in Rheumatoid Arthritis: A COM-B Model Informed Qualitative StudyHannah Shafi, Christopher J Armitage, Suzanne M M Verstappen, et al.
Rheumatology (Oxford, England)|May 25, 2012
Expression of the autoimmunity associated TNFAIP3 is increased in rheumatoid arthritis but does not differ according to genotype at 6q23James R Maxwell, Isobel R Gowers, Kar-Ping Kuet, et al.
Rheumatology (Oxford, England)|February 19, 2021
Do people with rheumatoid arthritis maintain their physical activity level at treatment onset over the first year of methotrexate therapy?James M Gwinnutt, Husain Alsafar, Kimme L Hyrich, et al.
Lancet (London, England)|August 28, 2015
Association of anti-carbamylated protein antibodies with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis RegisterJennifer Humphreys, Marije Verheul, Anne Barton, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 8, 2019
Profiling of Gene Expression Biomarkers as a Classifier of Methotrexate Nonresponse in Patients With Rheumatoid ArthritisDarren Plant, Mateusz Maciejewski, Samantha Smith, et al.
Arthritis Research & Therapy|February 2, 2011
Subtype specific genetic associations for juvenile idiopathic arthritis: ERAP1 with the enthesitis related arthritis subtype and IL23R with juvenile psoriatic arthritisAnne Hinks, Paul Martin, Edward Flynn, et al.
Pageof 30

Showing results (81-90 of 296) with videos related to

Sort By:
Pageof 30
Rheumatology Advances in Practice|February 28, 2024
Psoriatic arthritis: the role of self-reported non-adherence, non-trough drug levels, immunogenicity and conventional synthetic DMARD co-therapy in adalimumab and etanercept responsePhilippa D K Curry, Andrew P Morris, Meghna Jani, et al.
Arthritis and Rheumatism|December 16, 2003
Genetic variation in CCR5 does not predict clinical outcome in inflammatory arthritisSally John, Simon Smith, Jonathan F Morrison, et al.
Rheumatology Advances in Practice|February 26, 2025
Ultrasound-guided synovial tissue biopsy for people with rheumatoid arthritis: a micro-costing studySainan Chang, Felice Rivellese, Katherine Payne, et al.
RMD Open|February 6, 2016
Psychological factors predict adherence to methotrexate in rheumatoid arthritis; findings from a systematic review of rates, predictors and associations with patient-reported and clinical outcomesHolly F Hope, James Bluett, Anne Barton, et al.
Patient Preference and Adherence|March 5, 2026
Development of a Complex Biofeedback-Based Intervention to Improve Methotrexate Adherence in Rheumatoid Arthritis: A COM-B Model Informed Qualitative StudyHannah Shafi, Christopher J Armitage, Suzanne M M Verstappen, et al.
Rheumatology (Oxford, England)|May 25, 2012
Expression of the autoimmunity associated TNFAIP3 is increased in rheumatoid arthritis but does not differ according to genotype at 6q23James R Maxwell, Isobel R Gowers, Kar-Ping Kuet, et al.
Rheumatology (Oxford, England)|February 19, 2021
Do people with rheumatoid arthritis maintain their physical activity level at treatment onset over the first year of methotrexate therapy?James M Gwinnutt, Husain Alsafar, Kimme L Hyrich, et al.
Lancet (London, England)|August 28, 2015
Association of anti-carbamylated protein antibodies with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis RegisterJennifer Humphreys, Marije Verheul, Anne Barton, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 8, 2019
Profiling of Gene Expression Biomarkers as a Classifier of Methotrexate Nonresponse in Patients With Rheumatoid ArthritisDarren Plant, Mateusz Maciejewski, Samantha Smith, et al.
Arthritis Research & Therapy|February 2, 2011
Subtype specific genetic associations for juvenile idiopathic arthritis: ERAP1 with the enthesitis related arthritis subtype and IL23R with juvenile psoriatic arthritisAnne Hinks, Paul Martin, Edward Flynn, et al.
Pageof 30